Cargando…
Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2
BACKGROUND: Solute carrier family 35 member A2 (SLC35A2), which belongs to the SLC35 solute carrier family of human nucleoside sugar transporters, has shown regulatory roles in various tumors and neoplasms. However, the function of SLC35A2 across human cancers remains to be systematically assessed....
Autores principales: | Xu, Shengshan, Chen, Xiguang, Fang, Jianxiong, Chu, Hongyu, Fang, Shuo, Zeng, Leli, Ma, Hansu, Zhang, Tianzhi, Chen, Yu, Wang, Tao, Zhang, Xin, Shen, Tao, Zheng, Youbin, Xu, Dongming, Lu, Zhuming, Pan, Yihang, Liu, Yuchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232969/ https://www.ncbi.nlm.nih.gov/pubmed/37275857 http://dx.doi.org/10.3389/fimmu.2023.1155182 |
Ejemplares similares
-
A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer
por: Xu, Shengshan, et al.
Publicado: (2022) -
Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022) -
Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study
por: Fang, Shuo, et al.
Publicado: (2022) -
CERN Bulletin Issue No. 33-35/2016
Publicado: (2016) -
CERN Bulletin Issue No. 33-35/2013
Publicado: (2013)